Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule.

Ghielmini, M; Schmitz, SF; Cogliatti, SB; Pichert, G; Hummerjohann, J; Waltzer, U; Fey, MF; Betticher, DC; Martinelli, G; Peccatori, F; Hess, U; Zucca, E; Stupp, R; Kovacsovics, T; Helg, C; Lohri, A; Bargetzi, M; Vorobiof, D; Cerni, T

Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule.

Détails

Demande d'une copie

ID Serval

serval:BIB_32478

Type

Article: article d'un périodique ou d'un magazine.

Collection

Publications

Institution

UNIL/CHUV

Titre

Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule.

Périodique

Blood

Auteur⸱e⸱s

Ghielmini M, Schmitz SF, Cogliatti SB, Pichert G, Hummerjohann J, Waltzer U, Fey MF, Betticher DC, Martinelli G, Peccatori F, Hess U, Zucca E, Stupp R, Kovacsovics T, Helg C, Lohri A, Bargetzi M, Vorobiof D, Cerni T

Statut éditorial

Publié

Date de publication

2004

Volume

103

Pages

4416-4423

OAI-PMH

oai:serval.unil.ch:BIB_32478

Création de la notice

19/11/2007 13:31

Dernière modification de la notice

20/08/2019 14:17

Données d'usage

SERVAL

serveur académique lausannois

Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule.

Détails